1. Home
  2. BEEM vs PMN Comparison

BEEM vs PMN Comparison

Compare BEEM & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Beam Global

BEEM

Beam Global

HOLD

Current Price

$1.41

Market Cap

27.8M

Sector

Technology

ML Signal

HOLD

Logo ProMIS Neurosciences Inc. (ON)

PMN

ProMIS Neurosciences Inc. (ON)

HOLD

Current Price

$15.88

Market Cap

23.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BEEM
PMN
Founded
2006
2004
Country
United States
Canada
Employees
N/A
N/A
Industry
Semiconductors
Pharmaceuticals and Biotechnology
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
27.8M
23.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BEEM
PMN
Price
$1.41
$15.88
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
3
Target Price
$4.00
$42.67
AVG Volume (30 Days)
603.6K
445.5K
Earning Date
11-14-2025
03-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$27,668,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$45.61
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.33
$6.27
52 Week High
$4.04
$39.75

Technical Indicators

Market Signals
Indicator
BEEM
PMN
Relative Strength Index (RSI) 40.76 72.65
Support Level $1.37 $8.96
Resistance Level $1.49 $17.40
Average True Range (ATR) 0.11 1.80
MACD -0.01 0.11
Stochastic Oscillator 15.67 57.88

Price Performance

Historical Comparison
BEEM
PMN

About BEEM Beam Global

Beam Global produces sustainable technology for electric vehicle (EV) charging, outdoor media, and energy security, without the construction, disruption, and costs of grid-tied solutions. Its products are founded upon its patented EV ARC and Solar Treelines and include BeamTrak patented solar tracking, and ARC Technology energy storage, along with EV charging, outdoor media, and disaster preparedness packages. From start to finish, the company develops, patents, designs, engineers, and manufactures renewably energized products that help the environment, empower communities, and keep people moving.

About PMN ProMIS Neurosciences Inc. (ON)

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.

Share on Social Networks: